Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Kevin Appareti, Global Director Medical Science Liaison at Philips Healthcare, gives a short but useful interview on his company's approach to KOL engagement